668. Deputy Seán Kyne asked the Minister for Health following approval of the new 4CMenB vaccine, which is developed by pharmaceutical company Novartis, by the European Medicines Agency, when it is envisaged the vaccine will be granted a licence for use in this State and also if consideration is being given to introducing a vaccination programme on account of the potential transformative benefits this vaccine has in fighting meningitis; and if he will make a statement on the matter. [54450/12]

Summary

668. Deputy Seán Kyne asked the Minister for Health following approval of the new 4CMenB vaccine, which is developed by pharmaceutical company Novartis, by the European Medicines Agency, when it is envisaged the vaccine will be granted a licence for use in this State and also if consideration is being given to introducing a vaccination programme on account of the potential transformative benefits this vaccine has in fighting meningitis; and if he will make a statement on the matter. [54450/12]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Vaccination Programme

  xml · EN · 4 December 2012

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.